APLIF.OB 외환 뉴스
Appili Therapeutics Says FDA Approves LIKMEZ Metronidazole Oral Suspension
Biopharmaceutical company Appili Therapeutics, Inc. (APLI.TO, APLIF.PK) announced Monday that its manufacturing and commercialization partner, Saptalis Pharmaceuticals, LLC received approval from the U.S. Food and Drug Administration (FDA) for Metronidazole Oral Suspension 500mg/5mL (ATI-1501).
RTTNews
|
1096 일 전
